Lornoxicam is a strong analgesic and anti-inflammatory NSAID with balanced cyclo-oxygenase (COX)-1/COX-2 inhibition and excellent tolerability. In the course of the development of selective COX-2 ...
Two-hundred and twenty eligible patients were randomised (lornoxicam = 110; diclofenac potassium = 110) between September 2003 and July 2004. Figure 1 illustrates patient flow through the study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback